Abim Certification Exam: Nephrology

Abim Certification Exam: Nephrology

7/12/16 Disclosures • I am site PI for the REPRISE study evaluating efficacy of ABIM CERTIFICATION tolvaptan in autosomal dominant polycystic kidney EXAM: NEPHROLOGY disease (Otsuka pharmaceuticals) JULY 2016 UCSF CME Division of NephroloGy Department of Medicine Meyeon Park, MD MAS As s is tant Pr ofes s or Roadmap for today • Glomerular diseases (30 min) ---------Scheduled 15 min break------- • Common electrolyte abnormalities (30 min) • Acid-base (45 min) • Acute kidney injury (20 min) GLOMERULAR DISEASES • Secondary hypertension (10 min) 1 7/12/16 Case Laboratory studies A 74 yo man is evaluated for a 5-month history of sinusitis • Hemoglobin 11.5 g/dl and intermittent otitis media. He has lost 9 lbs (4.1 kg) • Leukocyte count 10.8x10^9 /L and has occasional joint pains. • Blood urea nitrogen 28 mg/dl Physical exam: Afebrile • Creatinine 1.6 m/dl HEENT: crusting in right nares; opaque right tympanic • Albumin 3.8 g/dl membrane; bilateral maxillary sinus tenderness • C3 100 mg/dl CV: 2/6 systolic murmur • C4 32 mg/dl Lungs: rhonchi • Urinalysis: 18 dysmorphic erythrocytes and 1 erythrocyte Extremities: 2+ edema bilateral lower ext cast/hpf • CXR: nodule in RUL, hazy density in LLL Case Question Case answer review A. Antinuclear antibody – lupus nephritis – wrong age / Which one of the following studies is most appropriate? sex – low complements A. Antinuclear antibody B. Anti-glomerular basement membrane antibody – wrong B. Anti-glomerular basement membrane antibody history; usually younger men; no respiratory C. Myeloperoxidase antineutrophil cytoplasmic antibody involvement D. Proteinase-3 antineutrophil cytoplasmic antibody C. Myeloperoxidase ANCA – can exist in granulomatous E. Anti-double-stranded DNA antibody polyangiitis (Wegener’s) but less specific D. Proteinase-3 ANCA – right answer – granulomatous polyangiitis E. Anti-double-stranded DNA antibody – lupus nephritis – wrong age / sex 2 7/12/16 Granulomatous polyangiitis (GPA) Glomerular diseases: ‘nephritic’ • Formerly known as Wegener’s granulomatosis • Hematuria, tea-colored urine • Granulomatous inflammation involving respiratory tract • Hypertension (often acute) and necrotizing vasculitis affecting small to medium sized • +/- Edema vessels • +/- Rapid loss of GFR • Necrotizing glomerulonephritis is common • Active urine sediment • Dysmorphic red blood cells • Red cell casts Glomerulonephritis: many ways to Vasculitis approach approach • Small vessel: microscopic polyangiitis, GPA, Churg- • Renal limited (mostly): IgA nephropathy, post-strep GN, Strauss, cryoglobulinemic, Henoch-Schonlein purpura– anti-GBM antibody disease inflammation / leukocyte infiltration; crescentic • Pulmonary-renal: Goodpasture’s syndrome, microscopic glomerulonephritis polyangiitis, Churg-Strauss, granulomatous polyangiitis • Renal-dermal: Henoch-Schonlein purpura; ANCA- • Medium-vessel: kawasaki’s disease, polyarteritis nodosa associated vasculitis; cryoglobulinemia; systemic lupus – renal infarctions / renovascular hypertension erythematosus • Systemic: systemic lupus erythematosus; HUS/TTP • Large-vessel: giant cell arteritis, Takayasu’s arteritis- renal ischemia due to narrowed abdominal aorta / renal arteries • Rapidly progressive GN: 50% eGFR loss in <30 days 3 7/12/16 ImmunoloGic approach Rapidly proGressive Glomerulonephritis Ser ologic analy s is • Immune complex mediated: Henoch-Schonlein purpura; cryoglobulinemic vasculitis; lupus; serum sickness; Anti-neutrophil cytoplasmic Anti-GBM Immune c omplex rheumatoid; polyarteritis nodosa; infection-induced; viral autoantibodies (ANCA) autoantibodies disease markers (hep B/C), bacterial (strep); Goodpasture’s (anti-GBM Others antibodies) No extra- Systemic Pulmonary Asthma Lung Anti-DNA Anti-pathogen renal necrotizing necrotizing and hemorrhage autoabs abs Cryoglobulins/ disease HCV • ANCA mediated (non-immune-complex mediated): GPA, arteritis granulomas eosinophilia No lung MPA, Churg-Strauss hemorrhage IgA Renal Microscopic Granulo- Churg- Goodpasture's Lupus GN Post-strep Cryo- • Cell-mediated: allograft cellular vascular rejection; giant limited polyangiitis matosis Strauss syndrome GN globulinemic vasculitis GN / MPGN cell arteritis; Takayasu’s with syndrome Anti-GBM polyangitis GN ANCA GN Anti-GBM GN Immune complex GN (‘pauci-immune’) Immune complex GN Immune complex GN • Post-streptococcal GN • SLE nephritis • Hematuria 2-3 weeks after pharyngitis or skin infection • Usually occurs within first 3 years of SLE diagnosis • Elevated ASO and anti-DNase B antibody • ANA, anti-dsDNA, anti-Smith antibodies • Low C3 / low-normal C4 • Immunosuppression: • No direct therapy available • Mycophenolate (CellCept) or cyclophosphamide • IgA nephropathy • Steroids (combined with above) • Synpharyngitic gross hematuria • Henoch-Schonlein Purpura (HSP) = Abdominal pain, diarrhea, often seen in kids, rarely in adults • Rx: steroids, fish oil(?), ACEi/ARB 4 7/12/16 Immune complex GN Anti-GBM antibody disease • Membranoproliferative glomerulonephritis (MPGN) type I • Antibodies to noncollagenous portion of type IV collagen causes autoantigen response • Secondary to cryoglobulinem ia, neoplasms, or chronic infections (eg HCV) • Renal limited: Anti-GBM Disease (older women) • Cryoglobulin deposits in vessels -> mesangiocapillar y GN • Pulmonary renal syndrome (hemoptysis / pulmonary hemorrhage + RPGN): Goodpasture’s Syndrome (young Caucasian men) • Low complements; + C3 nephritic factor (autoantibody against C3 convertase of alternative complement activation pathway) • Anti-GBM titer, kidney biopsy • Cryos: arthralgias, purpura, livedo reticularis • Rx: Plasmapheres is, steroids, cyclophosphamide • Rx: Underlying HCV à interferon and ribavirin ANCA Pauci-Immune GN /ANCA Vasculitis • Antineutrophil Cytoplasmic Antibodies • Diagnosis: ANCA +, normal complements, no • ANCAs react with cytoplasmic antigens (PR3 and MPO) that are immunohistologic evidence for vascular immune complex present at surface of cytokine-stimulated leukocytes, causing localization on biopsy leukocytes to adhere to vessel walls, degranulate, and generate toxic oxygen metabolites • Microscopic polyangiitis (p-ANCA) • Specific for proteins within granules of neutrophils and monocytes • Necrotizing vasculitis; no granulomas • Cytoplasmic (c-ANCA) versus perinuclear (p-ANCA) • Granulomatosis with polyangiitis (c-ANCA) • Cytoplasmic = PR3 (serine proteinase) = more common in GPA • Lung disease, upper airway disease, granulomas (Wegener) • Churg-Strauss Disease (p-ANCA or ANCA neg) • Perinuclear = myeloperoxidas e (MPO) = more common in MPA • Eosinophilia, asthma, sinus disease, peripheral neuropathy, (microscopic polyangiitis) granulomas • Treatment: Steroids, cyclophosphamide (+/- pheresis if hemoptysis, GPA) 5 7/12/16 IgA and SLE: Chameleons Case Both IgA Nephropathy and SLE can be… A 67 yo man with a h/o osteoarthritis, BPH, hyperlipidemia • Indolent or rapidly progressive is evaluated for new-onset joint pain in shoulders • Crescentic GN accompanied by lower extremity swelling. 3 months ago, • Nephritic and/or nephrotic baseline kidney function was normal. Meds include tamsulosin, simvastatin, naproxen. IgA Nephropathy Physical examination reveals BP 132/68. • More common in Asians and Hispanics HEENT: pale conjunctivae • Episodic macrohematuria Cardiac: S3 gallop SLE Pulmonary: decreased breath sounds at bases • More common in Asians, Hispanics, African-Americans Ext: 3+ LE edema • Up to 75% with SLE have renal disease; usually presents with proteinuria Case, continued Case Question Labs Which of the following studies is most likely to confirm the • Hemoglobin 8.2 g/dl cause of this patient’s kidney failure? • Leukocyte count 8.1 x10^9/L • Platelets 132k/mcL A. ANCA antibodies • BUN 68 mg/dl, Creatinine 5.6 mg/dl B. Serum protein electrophoresis / urine protein • Na 131 / k 3.5 / Cl 110 / Bicarb 18 / Albumin 3 / Anion electrophoresis gap 3 C. Urine eosinophil measurement • Ca 10.5 / Phos 5.4 • UA: pH 5, SG 1.015, no blood, 2+ protein D. Hepatitis C antibody assay • Urine protein:creatinine ratio 5 mg/g E. kidney ultrasonography 6 7/12/16 Case answer review Nephrotic disease: Amyloidosis A. ANCA antibodies – no hematuria • Pathology B. Serum protein electrophoresis / urine protein • β pleated structure that forms 8-10 nm fibrils electrophoresis – right answer – amyloidosis, multiple • Congo Red stain has apple-green birefringence with polarized light myeloma – low anion gap (increase in unmeasured • Classification cations including immunoglobulins) • ~ 20 unique amyloidoses • AL (primary) amyloidosis C. Urine eosinophil measurement – wrong history; test no • myeloma and monoclonal gammopathies longer favored even in AIN • AA (secondary) amyloidosis D. Hepatitis C antibody assay – MPGN can be nephrotic • chronic infections, inflammatory states (inflammatory bowel disease, rheumatoid arthritis, familial Mediterranean fever) and associated with RPGN, but no hematuria E. kidney ultrasonography – dx obstructive uropathy in older man with BPH, but more going on here Nephrotic Disease: Amyloidosis Nephrotic Disease: Amyloidosis • Clinical findings • Treatment • Large kidneys and massive proteinuria • AA Amyloidosis: Treat underlying infection or inflammation, • Multi-organ involvement colchicine for Familial Mediterranean Fever • Periorbital hemorrhage (raccoon sign), macroglossia • AL Amyloidosis: Treat underlying myeloma, melphalan, prednisone, • Cardiac deposits stem-cell transplant • GI involvement, hepatomegaly • Adjuvant therapy: ACEi/ARB, blood pressure control, diuretics,

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    39 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us